These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2625290)

  • 1. [Long-term follow-up of deterioration of the visual field in visual acuity in retinitis pigmentosa].
    Schmidt JG; Zinser J
    Fortschr Ophthalmol; 1989; 86(6):614-8. PubMed ID: 2625290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease course of patients with pericentral retinitis pigmentosa.
    Sandberg MA; Gaudio AR; Berson EL
    Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields.
    Gränse L; Ponjavic V; Andréasson S
    Acta Ophthalmol Scand; 2004 Dec; 82(6):701-6. PubMed ID: 15606467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and consistency of dark-adapted psychophysical measures in advanced eye disease.
    Kiser AK; Mladenovich D; Eshraghi F; Bourdeau D; Dagnelie G
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):444-52. PubMed ID: 16384995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural course of ocular function in pigmented paravenous retinochoroidal atrophy.
    Choi JY; Sandberg MA; Berson EL
    Am J Ophthalmol; 2006 Apr; 141(4):763-5. PubMed ID: 16564825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual stabilization of posture in retinitis pigmentosa and in artificially restricted visual fields.
    Turano K; Herdman SJ; Dagnelie G
    Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):3004-10. PubMed ID: 8360031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations.
    Berson EL; Rosner B; Weigel-DiFranco C; Dryja TP; Sandberg MA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3027-36. PubMed ID: 12202526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of central retinal function in patients with advanced retinitis pigmentosa.
    Gerth C; Wright T; Héon E; Westall CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1312-8. PubMed ID: 17325178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
    Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screen of the IMPDH1 gene among patients with dominant retinitis pigmentosa and clinical features associated with the most common mutation, Asp226Asn.
    Wada Y; Sandberg MA; McGee TL; Stillberger MA; Berson EL; Dryja TP
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1735-41. PubMed ID: 15851576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts.
    Virgili G; Pierrottet C; Parmeggiani F; Pennino M; Giacomelli G; Steindler P; Menchini U; Orzalesi N;
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3418-24. PubMed ID: 15452044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fourier-domain optical coherence tomography and microperimetry findings in retinitis pigmentosa.
    Lupo S; Grenga PL; Vingolo EM
    Am J Ophthalmol; 2011 Jan; 151(1):106-11. PubMed ID: 21094934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neural retinal transplantation.
    Humayun MS; de Juan E; del Cerro M; Dagnelie G; Radner W; Sadda SR; del Cerro C
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3100-6. PubMed ID: 10967070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa.
    Sandberg MA; Weigel-DiFranco C; Rosner B; Berson EL
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1693-8. PubMed ID: 8675413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transplantation of human fetal neuroretinal cells in advanced retinitis pigmentosa patients: results of a long-term safety study.
    Das T; del Cerro M; Jalali S; Rao VS; Gullapalli VK; Little C; Loreto DA; Sharma S; Sreedharan A; del Cerro C; Rao GN
    Exp Neurol; 1999 May; 157(1):58-68. PubMed ID: 10222108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between visual acuity and central retinal thickness in retinitis pigmentosa.
    Sandberg MA; Brockhurst RJ; Gaudio AR; Berson EL
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3349-54. PubMed ID: 16123439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.